Compare Stocks: CLPT, CNMD, DRTS, and IART

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.97 +1.7%	$14.57	$8.27 ▼ $30.10	$366.45M	1.26	714,140 shs	104,753 shs
CNMD CONMED	$46.27 -0.9%	$47.79	$31.44 ▼ $53.66	$1.39B	0.9	514,549 shs	10,374 shs
DRTS Alpha Tau Medical	$15.11 -0.6%	$14.06	$3.43 ▼ $15.79	$1.36B	1.2	589,389 shs	39,946 shs
IART Integra LifeSciences	$16.43 -1.3%	$16.93	$8.70 ▼ $20.49	$1.29B	1.21	876,543 shs	34,701 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	-23.12%	-25.46%	-24.31%	-37.13%	-45.43%
CNMD CONMED	+0.43%	+0.71%	-6.53%	+42.58%	+2.25%
DRTS Alpha Tau Medical	+1.00%	+0.33%	+3.76%	+20.17%	+257.41%
IART Integra LifeSciences	+2.27%	+3.87%	-1.48%	-6.99%	+22.08%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.97 +1.7%	$14.57	$8.27 ▼ $30.10	$366.45M	1.26	714,140 shs	104,753 shs
CNMD CONMED	$46.27 -0.9%	$47.79	$31.44 ▼ $53.66	$1.39B	0.9	514,549 shs	10,374 shs
DRTS Alpha Tau Medical	$15.11 -0.6%	$14.06	$3.43 ▼ $15.79	$1.36B	1.2	589,389 shs	39,946 shs
IART Integra LifeSciences	$16.43 -1.3%	$16.93	$8.70 ▼ $20.49	$1.29B	1.21	876,543 shs	34,701 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	-23.12%	-25.46%	-24.31%	-37.13%	-45.43%
CNMD CONMED	+0.43%	+0.71%	-6.53%	+42.58%	+2.25%
DRTS Alpha Tau Medical	+1.00%	+0.33%	+3.76%	+20.17%	+257.41%
IART Integra LifeSciences	+2.27%	+3.87%	-1.48%	-6.99%	+22.08%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	2.33	Hold	$25.67	114.50% Upside
CNMD CONMED	1.88	Reduce	$41.40	-10.52% Downside
DRTS Alpha Tau Medical	2.38	Hold	$15.40	1.95% Upside
IART Integra LifeSciences	1.88	Reduce	$18.86	14.77% Upside

Current Analyst Ratings Breakdown

Latest CLPT, CNMD, DRTS, and IART Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/17/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/3/2026	DRTS Alpha Tau Medical	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $30.00
9/1/2026	DRTS Alpha Tau Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/14/2026	IART Integra LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	CNMD CONMED	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/11/2026	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $16.00
8/5/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/4/2026	CLPT ClearPoint Neuro	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
8/4/2026	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$22.00
8/3/2026	DRTS Alpha Tau Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/30/2026	IART Integra LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 9/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$42.28M	8.63	N/A	N/A	$0.99 per share	12.09
CNMD CONMED	$1.37B	1.01	$7.17 per share	6.45	$33.36 per share	1.39
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
IART Integra LifeSciences	$1.65B	0.78	$4.27 per share	3.85	$13.40 per share	1.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$25.54M	-$1.18	N/A	N/A	N/A	-81.76%	-188.09%	-40.88%	11/5/2026 (Estimated)
CNMD CONMED	$47.06M	$1.85	25.02	9.78	2.12	4.12%	14.31%	6.33%	11/4/2026 (Estimated)
DRTS Alpha Tau Medical	-$42.63M	-$1.04	N/A	N/A	N/A	N/A	-138.12%	-81.68%	11/19/2026 (Estimated)
IART Integra LifeSciences	-$516.47M	-$0.09	N/A	6.39	0.84	-0.44%	18.30%	5.30%	10/29/2026 (Estimated)

Latest CLPT, CNMD, DRTS, and IART Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.1409	-$0.50	-$0.3591	-$0.50	$0.14 million	N/A
8/3/2026	Q2 2026	CLPT ClearPoint Neuro	-$0.2867	-$0.38	-$0.0933	-$0.38	$12.73 million	$10.88 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million
7/29/2026	Q2 2026	IART Integra LifeSciences	$0.4805	$0.56	+$0.0795	$0.06	$417.54 million	$418.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
CNMD CONMED	$0.60	1.30%	-5.59%	32.43%	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	4.66	4.74	3.89
CNMD CONMED	0.63	1.48	0.69
DRTS Alpha Tau Medical	0.15	11.09	7.79
IART Integra LifeSciences	1.75	3.60	2.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
CNMD CONMED	N/A
DRTS Alpha Tau Medical	2.65%
IART Integra LifeSciences	84.78%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.94%
CNMD CONMED	0.28%
DRTS Alpha Tau Medical	39.50%
IART Integra LifeSciences	3.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	172	30.50 million	28.39 million	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
DRTS Alpha Tau Medical	121	90.33 million	54.65 million	No Data
IART Integra LifeSciences	4,427	77.77 million	74.79 million	Optionable

CLPT, CNMD, DRTS, and IART Headlines

Recent News About These Companies

Integra LifeSciences Announces Enrollment Of 100th Patient In AERA Pediatric Registry

September 29 at 7:44 PM | marketscreener.comM

Integra LifeSciences Enrolls 100th Patient In AERA Pediatric Registry

September 29 at 2:43 PM | rttnews.com

IART or PEN: Which Is the Better Value Stock Right Now?

September 29 at 12:41 PM | zacks.com

Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

September 29 at 8:30 AM | globenewswire.com

Integra LifeSciences (NASDAQ:IART) Share Price Crosses Above 200-Day Moving Average - What's Next?

September 26, 2026 | americanbankingnews.com

Integra LifeSciences (NASDAQ:IART) Stock Crosses Above 200 Day Moving Average - Time to Sell?

September 26, 2026 | marketbeat.com

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

September 25, 2026 | globenewswire.com

Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow

September 23, 2026 | finance.yahoo.com

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Analysts

September 23, 2026 | americanbankingnews.com

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Average Recommendation of "Reduce" from Analysts

September 18, 2026 | marketbeat.com

Integra LifeSciences (NASDAQ:IART) Trading Down 3.7% - What's Next?

September 17, 2026 | marketbeat.com

Here's Why Integra LifeSciences (IART) is a Strong Value Stock

September 17, 2026 | zacks.com

Integra LifeSciences Holdings Corporation (IART) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 15, 2026 | seekingalpha.com

WINTON GROUP Ltd Purchases Shares of 102,632 Integra LifeSciences Holdings Corporation $IART

September 12, 2026 | marketbeat.com

Q2 earnings outperformers: Integra LifeSciences (NASDAQ:IART) and the rest of the surgical equipment & consumables - specialty stocks

September 10, 2026 | msn.com

Wellington Management Group LLP Has $26.24 Million Holdings in Integra LifeSciences Holdings Corporation $IART

September 6, 2026 | marketbeat.com

Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

September 4, 2026 | globenewswire.com

Bank of New York Mellon Corp Makes New Investment in Integra LifeSciences Holdings Corporation $IART

September 3, 2026 | marketbeat.com

Integra LifeSciences: Strong Q2 2026 Results Support Recovery Thesis

September 2, 2026 | seekingalpha.com

Integra LifeSciences (NASDAQ:IART) Share Price Passes Above 200-Day Moving Average - Here's Why

September 2, 2026 | marketbeat.com

Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?

August 28, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, CNMD, DRTS, and IART Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$11.97 +0.20 (+1.67%)

As of 10:20 AM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

CONMED NYSE:CNMD

$46.27 -0.42 (-0.91%)

As of 10:20 AM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Alpha Tau Medical NASDAQ:DRTS

$15.11 -0.08 (-0.55%)

As of 10:20 AM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Integra LifeSciences NASDAQ:IART

$16.43 -0.21 (-1.26%)

As of 10:20 AM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CLPT, CNMD, DRTS, and IART Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CLPT, CNMD, DRTS, and IART Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CLPT, CNMD, DRTS, and IART Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, CNMD, DRTS, and IART Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Integra LifeSciences NASDAQ:IART

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CLPT, CNMD, DRTS, and IART Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CLPT, CNMD, DRTS, and IART Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CLPT, CNMD, DRTS, and IART Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLPT, CNMD, DRTS, and IART Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Integra LifeSciences NASDAQ:IART

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools